Hydrocortisone Acetate
RxNorm 1291082· HYDROCORTISONE ACETATE· RECTAL
AARNA USA INC.
Indications and usage
INDICATIONS AND USAGE Hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of anorectum, and pruritus ani.
Dosage and administration
DOSAGE AND ADMINISTRATION FOR RECTAL ADMINISTRATION Detach one suppository from strip of suppositories. Hold suppository upright and carefully separate tabs at top opening and pull downward from the pointed end to expose the suppository. Remove the suppository from the pocket. Avoid excessive handling of suppository which is designed to melt at body temperature. Insert one suppository rectally, pointed end first. Insert one suppository in the rectum twice daily, morning and night for two weeks, in nonspecific proctitis. In more severe cases, one suppository three times a day or two suppositories twice daily. In factitial proctitis, the recommended duration of therapy is six to eight weeks or less, according to the response of the individual case.
Contraindications
CONTRAINDICATIONS Hydrocortisone acetate suppositories are contraindicated in those patients having a history of hypersensitivity to hydrocortisone acetate or any of the components.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- off label use10,545
- drug ineffective8,996
- fatigue7,276
- condition aggravated6,480
- rash6,123
- pain5,894
- nausea5,535
- diarrhoea5,177
- arthralgia5,172
- headache5,072
- dyspnoea4,963
- pyrexia4,543
- infusion related reaction4,515
- vomiting4,487
- pruritus4,262
- malaise4,072
Adverse reactions (label)
ADVERSE REACTIONS The following local adverse reactions have been reported with hydrocortisone acetate suppositories; burning, itching, irritation, dryness, folliculitis, hypopigmentation, allergic contact dermatitis, secondary infection. To report an adverse event, please contact AARNA USA INC at 1-877-225-6999.
View more: Full FDA label on DailyMed →Label effective 20260416